Claes Held

38.4k total citations · 6 hit papers
275 papers, 15.2k citations indexed

About

Claes Held is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Claes Held has authored 275 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Cardiology and Cardiovascular Medicine, 48 papers in Surgery and 23 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Claes Held's work include Antiplatelet Therapy and Cardiovascular Diseases (72 papers), Acute Myocardial Infarction Research (62 papers) and Atrial Fibrillation Management and Outcomes (56 papers). Claes Held is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (72 papers), Acute Myocardial Infarction Research (62 papers) and Atrial Fibrillation Management and Outcomes (56 papers). Claes Held collaborates with scholars based in Sweden, United States and United Kingdom. Claes Held's co-authors include Lars Wallentin, Stefan James, Kenneth W. Mahaffey, Robert A. Harrington, Philippe Gabríel Steg, Robert F. Storey, Richard C. Becker, Steen Husted, Christopher P. Cannon and Jay Horrow and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Claes Held

262 papers receiving 14.7k citations

Hit Papers

Ticagrelor versus Clopidogrel in Patients with Acute Coro... 2009 2026 2014 2020 2009 2016 2016 2017 2019 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claes Held Sweden 55 11.3k 4.2k 2.6k 1.3k 1.2k 275 15.2k
Felicita Andreotti Italy 45 10.1k 0.9× 5.8k 1.4× 1.5k 0.6× 1.2k 0.9× 2.6k 2.2× 179 15.2k
Karen S. Pieper United States 60 11.9k 1.1× 4.1k 1.0× 1.6k 0.6× 1.3k 1.0× 3.1k 2.6× 250 15.5k
Marcus Flather United Kingdom 58 13.3k 1.2× 5.6k 1.3× 1.1k 0.4× 1.3k 1.1× 3.1k 2.6× 238 16.8k
Joseph C. Cleveland United States 48 15.7k 1.4× 3.6k 0.8× 2.6k 1.0× 2.1k 1.7× 1.2k 1.0× 207 20.1k
Jaap W. Deckers Netherlands 50 7.4k 0.7× 2.9k 0.7× 725 0.3× 939 0.8× 2.0k 1.7× 201 10.7k
Nicolas Danchin France 61 10.8k 1.0× 5.4k 1.3× 771 0.3× 1.1k 0.9× 3.0k 2.5× 580 15.6k
Karen P. Alexander United States 61 11.7k 1.0× 4.5k 1.1× 925 0.4× 1.5k 1.2× 3.0k 2.6× 245 16.2k
Philip E. Aylward Australia 50 8.9k 0.8× 3.5k 0.8× 1.4k 0.5× 644 0.5× 2.3k 2.0× 223 11.1k
Renato D. Lópes United States 73 14.9k 1.3× 4.6k 1.1× 4.0k 1.6× 2.3k 1.8× 1.4k 1.1× 623 21.5k
José Carlos Nicolau Brazil 46 4.8k 0.4× 2.7k 0.6× 829 0.3× 717 0.6× 974 0.8× 339 9.3k

Countries citing papers authored by Claes Held

Since Specialization
Citations

This map shows the geographic impact of Claes Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes Held more than expected).

Fields of papers citing papers by Claes Held

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claes Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes Held. The network helps show where Claes Held may publish in the future.

Co-authorship network of co-authors of Claes Held

This figure shows the co-authorship network connecting the top 25 collaborators of Claes Held. A scholar is included among the top collaborators of Claes Held based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claes Held. Claes Held is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bäck, Maria, Peter Henriksson, John Wallert, et al.. (2025). Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study. European Journal of Cardiovascular Nursing. 24(2). 253–263. 1 indexed citations
2.
Karlström, Patric, Troels Yndigegn, Tomas Jernberg, et al.. (2024). Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial. European Heart Journal Acute Cardiovascular Care. 13(11). 789–797. 1 indexed citations
3.
Held, Claes, et al.. (2024). Association of anxiety and recurrent cardiovascular events: investigating different aspects of anxiety. European Journal of Cardiovascular Nursing. 23(7). 720–727. 8 indexed citations
4.
Kjøller‐Hansen, Lars, Akiko Maehara, Henning Kelbæk, et al.. (2024). Impact of Lipidic Plaque on In-Stent and Stent Edge–Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy. Circulation Cardiovascular Interventions. 17(10). e014215–e014215.
5.
Batra, Gorav, Nermin Hadziosmanovic, Emil Hagström, et al.. (2024). Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy. European Journal of Preventive Cardiology. 32(6). 456–465. 1 indexed citations
6.
Davidsson, Pia, Susanna Eketjäll, Niclas Eriksson, et al.. (2023). Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease. Cardiovascular Research. 119(7). 1596–1605. 8 indexed citations
7.
Yndigegn, Troels, Bertil Lindahl, Joakim Alfredsson, et al.. (2022). Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). European Heart Journal - Cardiovascular Pharmacotherapy. 9(2). 192–197. 15 indexed citations
8.
Held, Claes, Nermin Hadziosmanovic, Johan Lindbäck, et al.. (2021). Risk markers of incident atrial fibrillation in patients with coronary heart disease. American Heart Journal. 233. 92–101. 6 indexed citations
9.
Rylance, Rebecca, Philippe Wagner, Elmir Ömerovic, et al.. (2021). Assessing the external validity of the VALIDATE-SWEDEHEART trial. Clinical Trials. 18(4). 427–435. 1 indexed citations
10.
Puthoopparambil, Soorej Jose, et al.. (2021). Self-perceived cognitive status and cognitive challenges associated with cardiac rehabilitation management: experiences of elderly myocardial infarction patients. Disability and Rehabilitation. 44(15). 3834–3842. 5 indexed citations
11.
Wallert, John, Claes Held, Ronnie Pingel, et al.. (2020). Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry. European Heart Journal Acute Cardiovascular Care. 10(4). 372–379. 14 indexed citations
12.
Ducrocq, Grégory, Phillip J. Schulte, Andrzej Budaj, et al.. (2015). Balancing the risk of ischaemic and bleeding events in ACS. European Heart Journal. 36. 860–861. 1 indexed citations
13.
Bahit, M. Cecilia, Renato D. Lópes, Daniel Wojdyla, et al.. (2015). Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation : insights from the ARISTOTLE trial. European Heart Journal. 36. 338–339. 3 indexed citations
14.
Held, Claes, Harvey D. White, Ralph Stewart, et al.. (2015). Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial. European Heart Journal. 36. 1104–1104.
15.
Armaganijan, Luciana, Renato D. Lópes, Zhen Huang, et al.. (2013). Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome : Insights From the TRACER Trial. Circulation. 128(22). 1 indexed citations
16.
Brilakis, Emmanouil S., Claes Held, Bernhard Meier, et al.. (2013). Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial. American Heart Journal. 166(3). 474–480. 23 indexed citations
17.
Tricoci, Pierluigi, Edmond Chen, Megan L. Neely, et al.. (2013). CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS : Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. Circulation. 128(22). 2 indexed citations
18.
Bennermo, Marie, Margareta Nordin, Pia Lundman, et al.. (2010). Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case–Control Study. Journal of Interferon & Cytokine Research. 31(2). 259–264. 34 indexed citations
19.
Rehnqvist, Nina, Paul Hjemdahl, Ewa Billing, et al.. (1996). Effects of metoprolol vs verapamil in patients with stable angina pectoris. European Heart Journal. 17(1). 483–483. 44 indexed citations
20.
Rehnqvist, Nina, Paul Hjemdahl, Ewa Billing, et al.. (1995). Treatment of stable angina pectoris with calcium antagonists and beta-blockers : The APSIS study. 40. 301–301. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026